Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
06/17/2021 06/18/2021 06/21/2021 06/22/2021 06/23/2021 Date
348.4(c) 348.25(c) 349.15(c) 345.3(c) 340.5(c) Last
1 481 920 4 238 079 1 490 564 1 344 901 1 182 168 Volume
+0.37% -0.04% +0.26% -1.10% -1.39% Change
More quotes
Estimated financial data (e)
Sales 2021 60 597 M 65 955 M 65 955 M
Net income 2021 14 513 M 15 796 M 15 796 M
Net cash position 2021 4 591 M 4 997 M 4 997 M
P/E ratio 2021 19,8x
Yield 2021 2,76%
Sales 2022 61 114 M 66 518 M 66 518 M
Net income 2022 15 397 M 16 758 M 16 758 M
Net cash position 2022 11 079 M 12 059 M 12 059 M
P/E ratio 2022 18,9x
Yield 2022 2,85%
Capitalization 295 B 322 B 321 B
EV / Sales 2021 4,79x
EV / Sales 2022 4,65x
Nbr of Employees 101 465
Free-Float 83,4%
More Financials
Company
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The... 
Sector
Pharmaceuticals
Calendar
06/22 | 02:30amPresentation
More about the company
Ratings of Roche Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about ROCHE HOLDING AG
06/22Insulin pump Accessories Market Development, Outline, Competitive perspective..
AQ
06/18Ahead of pivotal AGM, Toshiba board chairman vows to be 'agent of positive ch..
RE
06/17ROCHE HOLDINGS AG  : Deutsche Bank reiterates its Neutral rating
MD
06/17Synlogic, Roche in Bowel-Disease Collaboration
DJ
06/17ROCHE  : Syncona CFO to Retire; Three New Executives Named
MT
06/17ROCHE  : Check You Employment Agreement's Restrictive Covenant
AQ
06/16WALL STREET STOCK EXCHANGE : How yesterday’s data could affect Fed policy
06/16Atea Pharma Hits Development Milestone for Covid-19 Treatment
DJ
06/16ROCHE  : Atea Pharmaceuticals Announces Achievement of AT-527 Development Milest..
AQ
06/16ROCHE  : Regeneron COVID-19 Antibody Cocktail Reduces Death Risk in Late-Stage T..
MT
06/15ELOXX PHARMACEUTICALS  : Roche Discloses 5.3% Stake in Eloxx Pharmaceuticals
MT
06/15ROCHE HOLDINGS AG  : Berenberg reaffirms its Neutral rating
MD
06/15ROCHE  : to Release Further Data on Therapies Across Neuroscience Portfolio
MT
06/15PRESS RELEASE  : Roche data at EAN 2021 showcase -3-
DJ
06/15PRESS RELEASE  : Roche data at EAN 2021 showcase -2-
DJ
More news
News in other languages on ROCHE HOLDING AG
12:10pROCHE : Chugai obtient l'homologation au Japon d'Evrysdi
12:05pRoche-Tochter Chugai erhält Zulassung in Japan für Evrysdi bei SMA
11:46aAktien Schweiz bauen Vortagesverluste deutlich aus
06/22Aktien Schweiz schließen knapp behauptet vor Fed-Aussagen
06/18La FDA homologue d'urgence un test PCR Covid de Roche
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Stock Trading Strategies
ROCHE HOLDING AG - 2020
Close to an important medium term support level
BUY
More Stock Trading Analysis
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | ROG | CH0012032048 | MarketScreener
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 340,50 CHF
Average target price 355,40 CHF
Spread / Average Target 4,38%
EPS Revisions
Managers and Directors
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
André S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING AG11.75%324 905
JOHNSON & JOHNSON3.34%430 876
PFIZER, INC.6.09%221 725
NOVARTIS AG2.56%209 282
ABBVIE INC.6.39%202 586
ELI LILLY AND COMPANY28.58%201 295